Yellow Fever Vaccine Market to Be Worth US$ 81.75 Million by 2025 Expanding at a CAGR of 4.3% According to New Research
Yellow fever is an acute viral fever caused by a mosquito-borne flavivirus. Most of these infections are asymptomatic. In those individuals who develop the condition, the clinical spectrum ranges from nonspecific flu-like illness with fever, malaise, prostration, headache, photophobia, generalized arthralgia and myalgia, nausea, and/or vomiting to potentially lethal pan systemic disease, most prominently involving the liver, kidneys, GI tract, and brain, with recrudescing fever, jaundice, renal failure, severe hemorrhage due to thrombocytopenia, and shock. The case mortality rate of...
View full press release